Effect of preischemic catecholamine treatment on ischemia-reperfusion injury of the myocardium: Subtype, dose, and temperature dependency

Japanese Circulation Journal

Volumn 62, Issue 7, 1998, Pages 517-526

  Shimada, Yasuyuki ^b   Yamamoto, Fumio ^a   Yamamoto, Hiroshi ^c   Oka, Takahiro ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Catecholamine; Ischemia reperfusion induced injury; Rat

Indexed keywords

ADRENALIN; DILTIAZEM; ISOPRENALINE; PHENYLEPHRINE; RYANODINE;

ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONDITIONING; DOSE RESPONSE; DRUG EFFECT; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIOPLEGIC SOLUTIONS; CATECHOLAMINES; HEART FUNCTION TESTS; ISOPROTERENOL; MALE; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; TEMPERATURE;

EID: 0031814635     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.517     Document Type: Article

References (37)

1. Griffith BP, Hardesty RL: Multiple cadaveric organ procurement for transplantation with emphasis on the heart. Surg Clin North Am 1986; 66: 451-457
2. Iwai A, Sakano T, Uenishi M, Sugimoto H, Yoshioka T, Sugimoto T: Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation 1989; 48: 613-617
3. Yau TM, Weisel RD, Mickle DAG, Ivanov J: Cardioplegia for the dysfunctional ventricle. In: Engelman RM, Levitsky S, editors. A textbook of cardioplegia for difficult clinical problems. New York: Futura, 1991: 83-94
4. Komai H, Yamamoto F, Tanaka L, Ichikawa H, Shibata T, Koide A, et al: Harmful effects of inotropic agents on myocardial protection. Ann Thorac Surg 1991; 52: 927-933
5. Shimada Y, Yamamoto F, Ohashi T, Kumada Y, Kagisaki K, Ishikawa T: Harmful effect of inotropic agents to the myocardial preservation (abstract). J Cardiovasc Surg 1991; 32(Suppl): 31
6. Hearse DJ, Braimbridge MV, Jynge P: Models and markers for the investigation of myocardial tissue damage. In: Protection of the ischemic myocardium: cardioplegia. New York: Raven Press, 1981: 50-92
7. Gerhardt W: Methods of enzymatic analysis III. Weinheim: Verlag Chemie, 1983: 510-518
8. Yamamoto F, Yamamoto H, Yoshida S, Ichikawa H, Takahashi A, Tanaka K, et al: The effects of several pharmacologic agents upon postischemic recovery. Cardiovasc Drugs Ther 1991; 5: 301-308
9. Steen PA, Tinker JH, Pluth JR, Barnhost DA, Tarhan S: Efficacy of dopamine, dobutamine and epinephrine during emergence from cardiopulmonary bypass in man. Circulation 1978; 57: 378-383
10. Sato Y, Matsuzawa H, Eguchi S: Comparative study of effects of adrenaline, dobutamine and dopamine on systemic hemodynamics and renal blood flow in patients following open heart surgery. Jpn Circ J 1982; 46: 1059-1072
11. Akera T: Pharmacological egents and myocardial calcium. In: Langer GA, editor. Calcium and the heart. New York: Raven Press, 1990: 299-331
12. Katz AM: Receptors, coupling proteins, and second messengers. In: Katz AM, editor. Physiology of the heart. New York: Raven Press, 1992: 274-302
13. Rona G: The significance of factors modifying the development of isoproterenol induced myocardial necrosis. Am Heart J 1963; 66: 389-395
14. Nirmala C, Puvanakrishnan R: Isoproterenol-induced myocardial infarction in rats: functional and biochemical alterations. Med Sci Res 1994; 22: 575-577
15. Chvapil M, Owen JA: Effect of zinc on acute and chronic isoproterenol induced heart injury. J Mol Cell Cardiol 1977; 9: 151-159
16. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS: Role of free radicals in catecholamine induced cardiomyopathy. Can J Physiol Pharmacol 1982; 60: 1390-1397
17. Opie LH, Walpoth B, Barsacchi R: Calcium and catecholamine: relevance to cardiomyopathies and significance in therapeutic strategies (abstract). J Mol Cell Cardiol 1985; 17(Suppl 2): 21-24
18. Opie LH: Receptors and signal transduction. In: Opie LH, editor. The Heart. New York: Raven Press, 1991: 147-175
19. + exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res 1993; 27: 915-924
20. + exchange and its inhibition in cardiac ischemia and reperfusion. Basic Res Cardiol 1993; 88: 443-455
21. Taylor CW, Merrit JE: Receptor coupling to polyphosphoinositide turnover: parallel with the adenylate cyclase system. Trends Pharmacol Sci 1986; 7: 238-242
22. 2+ (letter). Cardiovasc Res 1994; 27: 2079-2080
23. 2+ exchange. Eur J Pharmacol 1990; 186: 29-40
24. Pierce GN: The role of sodium-proton exchange in ischemic/ reperfusion injury in the heart. Am J Cardiovasc Pathol 1992; 4: 91-102
25. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M: Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning. Am J Physiol 1994; 266: H2033-H2041
26. Vegh A, Szekeres L, Parratt JR: Transient ischemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res 1991; 25: 1051-1053
27. Seibert AF, Thompson WJ, Taylor A, Wilborn WH, Barnard J, Haynes J: Reversal of increased microvascular permiability associated with ischemia-reperfusion: Role of cAMP. J Appl Physiol 1992; 72: 389-395
28. Kennedy TP, Michael JR, Hasty D, Sciuto AM, Hopkins C, Lazar R, et al: Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene. J Appl Physiol 1989; 67: 2542-2552
29. Tranum-Jensen J, Janse MJ, Fiolet JWT, Krieger WJG, d'Alnoncourt CN, Durrer D: Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart. Circ Res 1981; 49: 364-381
30. Rubboli A, Sobotka PA, Euler DE: Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am J Physiol 1994; 267: H1054-H1061
31. Steenbergen C, Hill ML, Jennings RB: Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro: effects of osmotic cell swelling on plasma membrane integrity. Circ Res 1985; 57: 864-875
32. Yeh T, Parmar JM, Rebeyka IM, Lofland GK, Allen EL, Dignan RJ, et al: Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch. J Thorac Cardiovasc Surg 1992; 104: 659-665
33. Warren JB, Wilson AJ, Loi RK, Coughlan ML: Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J 1993; 7: 1394-1400
34. Schömig A, Richardt G: The role of catecholamines in ischemia. J Cardiovasc Pharmacol 1990; 16: S105-S112
35. Jamieson WRE: Cardioplegic additives: the importance of optimization of dose. In: Roberts AJ, editor. Myocardial protection in cardiac surgery. New York: Marcel Dekker, 1987: 321-362
36. Christakis GT, Weisel RD, Mickle DAG, Ivanov J, Madonik MM, Benak AM, et al: Calcium antagonists for myocardial protection. In: Roberts AJ, editor. Myocardial protection in cardiac surgery. New York: Marcel Dekker, 1987: 413-433
37. Yamamoto F, Manning AS, Braimbridge MV, Hearse DJ: Cardioplegia and slow calcium-channel blockers: Studies with verapamil. J Thorac Cardiovasc Surg 1983; 86: 252-261